AKRO: Akero Therapeutics, Inc. Stock

by  •  • Comments Off on AKRO: Akero Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3,188.76
Enterprise Value ($M) 2,538.69
Book Value ($M) 1,083.85
Book Value / Share 13.60
Price / Book 2.94
NCAV ($M) 641.15
NCAV / Share 8.05
Price / NCAV 4.97

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 16.80
Current Ratio 16.80

Balance Sheet (mrq) ($M)
Current Assets 713.15
Assets 1,155.84
Liabilities 72.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -285.42
Net Income -252.06
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -230.11
Cash from Investing -109.71
Cash from Financing 445.85

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
16 hours ago 13G/A Janus Henderson Group Plc 8.90 17.15
2 days ago 13G/A Wellington Management Group Llp 7.50 -24.83
02-14 13G/A Rtw Investments, Lp 9.80 15.89
11-14 13G/A Price T Rowe Associates Inc /md/ 5.50 3.45
11-13 13G/A Alkeon Capital Management Llc 4.80 -11.67
10-17 13G/A State Street Corp 3.60 -51.14

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q SUMMARY OF THE MATERIAL RISKS ASSOCIATED WITH OUR BUSINESS PART I—FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements 1. Nature of the business and basis of presentation 2. Summary of significant accounting policies 4. Short and
2025-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-08 10-Q 33 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-09 10-Q 33 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 172,764 846,780 20.40
2025-05-12 170,952 1,429,267 11.96
2025-05-09 162,317 1,230,484 13.19
2025-05-08 198,837 1,151,340 17.27

(click for more detail)

Similar Companies
ACT – Enact Holdings, Inc. ADPT – Adaptive Biotechnologies Corporation
AGIO – Agios Pharmaceuticals, Inc. ALEC – Alector, Inc.
ALKS – Alkermes plc


Financial data and stock pages provided by
Fintel.io